Photo: freedigitialphoto.net_moggara12

There is no negating that chemotherapy saves lives every day. But the treatment often takes a toll on the rest of the body.

As a result, the patient can be dealing with a newly developed case of chronic pain.

One of the root causes of this pain is a result of the toxicity of the heavy metals, Taxanes and Cisplatinin, particularly.

Chemotherapy-induced peripheral neuropathy (CIPN), is a debilitating side effect for 30 – 40 percent of cancer patients resulting in sharp, ongoing pain in the hands and feet. It affects as many as four million cancer patients in the United States alone.

Calmare Pain Therapy Treatment has proven, through formal clinical trial results, to be particularly effective in combating debilitating chronic pain as a result of chemotherapy.

To learn more:

Medscape reports on another positive clinical trial using Calmare for cancer pain (January 2016)

Reuters News Service reports on clinical trial success of Mayo Clinic oncologist Dr. Charles L. Loprinzi (10.2014):

Scrambler Therapy (Calmare MC5-A) Clinical Study Findings

2012 Calmare NJ Patient Story  – Chemotherapy-induced Peripheral Neuropathy (CIPN)

Photo Courtesy of freedigitialphoto.net_moggara12